Ligand Pharmaceuticals
LGND
#3601
Rang
€3.12 Md
Capitalisation boursière
158,78 €
Prix de l'action
-1.93%
Changement (1 jour)
36.09%
Changement (1 an)

Ligand Pharmaceuticals (LGND) - Dette totale

Dette totale au bilan au Septembre 2025 : 0.38 Milliard d'euros

Selon les derniers rapports financiers de Ligand Pharmaceuticals, la dette totale de l'entreprise est de 0.38 Milliard d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Ligand Pharmaceuticals - Dette totale au bilan (de 1996 à 2025)

Dette totale par année

Année Dette totale Changement
2024-12-31€6.82 M22.43%
2023-12-31€5.57 M-93.18%
2022-12-31€81.8 M-71.44%
2021-12-31€0.28 Md-22.81%
2020-12-31€0.37 Md-36.07%
2019-12-31€0.58 Md4.35%
2018-12-31€0.55 Md197.23%
2017-12-31€0.18 Md-7.55%
2016-12-31€0.20 Md9.57%
2015-12-31€0.18 Md14.68%
2014-12-31€0.16 Md2342.14%
2013-12-31€6.59 M-69.15%
2012-12-31€21.37 M-8.33%
2011-12-31€23.32 M35.75%
2010-12-31€17.17 M-32.15%
2009-12-31€25.31 M-31.31%
2008-12-31€36.86 M2397.47%
2007-12-31€1.47 M-95.37%
2006-12-31€31.88 M-78.16%
2005-12-31€0.14 Md13.79%
2004-12-31€0.12 Md-6.39%
2003-12-31€0.13 Md-8.95%
2002-12-31€0.15 Md-6.47%
2001-12-31€0.16 Md12.15%
2000-12-31€0.14 Md2.56%
1999-12-31€0.13 Md77.21%
1998-12-31€78.96 M72.88%
1997-12-31€45.67 M-4.24%
1996-12-31€47.69 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
Amgen
AMGN
€46.88 Md 12,003.63%🇺🇸 USA
Spectrum Pharmaceuticals
SPPI
€24.77 M-93.61%🇺🇸 USA
GlaxoSmithKline
GSK
€20.49 Md 5,190.94%🇬🇧 UK
Merck
MRK
€35.53 Md 9,073.90%🇺🇸 USA
Pfizer
PFE
€52.26 Md 13,391.89%🇺🇸 USA
Eli Lilly
LLY
€36.50 Md 9,325.03%🇺🇸 USA
Bristol-Myers Squibb
BMY
€43.83 Md 11,217.37%🇺🇸 USA
Baxter
BAX
€8.34 Md 2,053.45%🇺🇸 USA
Johnson & Johnson
JNJ
€39.33 Md 10,054.17%🇺🇸 USA